Kristian Humer - 09 Dec 2025 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Chief Financial Officer
Signature
/s/ Scott Bizily as Attorney-in-Fact for Kristian Humer
Issuer symbol
FDMT
Transactions as of
09 Dec 2025
Net transactions value
$0
Form type
4
Filing time
11 Dec 2025, 16:18:02 UTC
Previous filing
17 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Humer Kristian Chief Financial Officer C/O 4D MOLECULAR THERAPEUTICS, INC., 5858 HORTON STREET #455, EMERYVILLE /s/ Scott Bizily as Attorney-in-Fact for Kristian Humer 11 Dec 2025 0001872280

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Award $0 +480,000 $0.000000 480,000 09 Dec 2025 Common Stock 480,000 $10.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option vest on the first anniversary measured from November 17, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.